Delaware | 000-50976 | 01-0666114 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification Number) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||
Emerging growth company | o | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | o |
Huron Consulting Group Inc. | |||
(Registrant) | |||
Date: | July 27, 2017 | /s/ John D. Kelly | |
John D. Kelly | |||
Executive Vice President, Chief Financial Officer, and Treasurer |
Exhibit Number | Description | |
99.1 | Press release, dated July 27, 2017 |
NEWS | MEDIA CONTACT | |
Sarah McHugh | ||
FOR IMMEDIATE RELEASE | 312-880-2624 | |
smchugh@huronconsultinggroup.com | ||
INVESTOR CONTACT | ||
John D. Kelly | ||
312-583-8722 | ||
investor@huronconsultinggroup.com |
• | Revenues were $181.4 million in Q2 2017 compared to $184.3 million in Q2 2016. |
• | Net loss from continuing operations, which includes a non-cash pretax goodwill impairment charge of $209.6 million related to the company's Healthcare segment, was $150.5 million in Q2 2017 compared to net income from continuing operations of $16.1 million in Q2 2016. |
• | Adjusted EBITDA(6), a non-GAAP measure, was $24.5 million in Q2 2017 compared to $41.6 million in Q2 2016. |
• | Diluted loss per share from continuing operations was $7.00 in Q2 2017 compared to diluted earnings per share from continuing operations of $0.76 in Q2 2016. |
• | Adjusted diluted earnings per share from continuing operations(6), a non-GAAP measure, was $0.49 in Q2 2017 compared to $1.09 in Q2 2016. |
• | Huron reorganized its internal financial reporting structure by moving its Life Sciences practice from the Education and Life Sciences segment to the Business Advisory segment. Historical segment data has been recast for consistent presentation. |
• | Revenues increased to $370.3 million for the first six months of 2017 compared to $364.7 million for the same period in 2016. |
• | Net loss from continuing operations was $145.3 million for the first six months of 2017, compared to net income from continuing operations of $23.0 million for the same period in 2016. |
• | Adjusted EBITDA(6) was $51.6 million for the first six months of 2017 compared to $68.3 million for the same period in 2016. |
• | Diluted loss per share from continuing operations was $6.80 for the first six months of 2017 compared to diluted earnings per share from continuing operations of $1.07 for the first six months of 2016. |
• | Adjusted diluted earnings per share from continuing operations(6) was $1.04 for the first six months of 2017 compared to $1.71 for the first six months of 2016. |
• | Huron updates full year 2017 guidance, including revenue expectations in a range of $730.0 million to $750.0 million. |
Three Months Ended June 30, | |||||||
2017 | 2016 | ||||||
Amortization of intangible assets | $ | 8,945 | $ | 8,153 | |||
Restructuring charges | $ | 3,669 | $ | 1,747 | |||
Other gains, net | $ | (1,102 | ) | $ | — | ||
Goodwill impairment charge | $ | 209,600 | $ | — | |||
Non-cash interest on convertible notes | $ | 1,951 | $ | 1,861 | |||
Gain on sale of business | $ | (931 | ) | $ | — | ||
Foreign currency transaction gains | $ | (81 | ) | $ | (7 | ) | |
Tax effect | $ | (61,070 | ) | $ | (4,622 | ) |
Six Months Ended June 30, | |||||||
2017 | 2016 | ||||||
Amortization of intangible assets | $ | 17,597 | $ | 15,598 | |||
Restructuring charges | $ | 3,948 | $ | 3,080 | |||
Other gains, net | $ | (1,102 | ) | $ | — | ||
Goodwill impairment charge | $ | 209,600 | $ | — | |||
Non-cash interest on convertible notes | $ | 3,879 | $ | 3,699 | |||
Gain on sale of business | $ | (931 | ) | $ | — | ||
Foreign currency transaction gains | $ | (64 | ) | $ | (354 | ) | |
Tax effect | $ | (65,262 | ) | $ | (8,794 | ) |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Revenues and reimbursable expenses: | |||||||||||||||
Revenues | $ | 181,418 | $ | 184,259 | $ | 370,267 | $ | 364,748 | |||||||
Reimbursable expenses | 20,930 | 18,982 | 37,880 | 35,543 | |||||||||||
Total revenues and reimbursable expenses | 202,348 | 203,241 | 408,147 | 400,291 | |||||||||||
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses): | |||||||||||||||
Direct costs | 113,669 | 103,099 | 229,410 | 214,956 | |||||||||||
Amortization of intangible assets and software development costs | 2,745 | 3,840 | 5,731 | 7,226 | |||||||||||
Reimbursable expenses | 20,953 | 19,164 | 37,822 | 35,791 | |||||||||||
Total direct costs and reimbursable expenses | 137,367 | 126,103 | 272,963 | 257,973 | |||||||||||
Operating expenses and other gains, net: | |||||||||||||||
Selling, general and administrative expenses | 43,705 | 39,624 | 90,561 | 81,681 | |||||||||||
Restructuring charges | 3,669 | 1,747 | 3,948 | 3,080 | |||||||||||
Other gains, net | (1,102 | ) | — | (1,102 | ) | — | |||||||||
Depreciation and amortization | 9,684 | 7,558 | 18,603 | 14,972 | |||||||||||
Goodwill impairment charge | 209,600 | — | 209,600 | — | |||||||||||
Total operating expenses and other gains, net | 265,556 | 48,929 | 321,610 | 99,733 | |||||||||||
Operating income (loss) | (200,575 | ) | 28,209 | (186,426 | ) | 42,585 | |||||||||
Other income (expense), net: | |||||||||||||||
Interest expense, net of interest income | (4,927 | ) | (4,123 | ) | (8,931 | ) | (8,094 | ) | |||||||
Other income, net | 1,516 | 276 | 2,274 | 747 | |||||||||||
Total other expense, net | (3,411 | ) | (3,847 | ) | (6,657 | ) | (7,347 | ) | |||||||
Income (loss) from continuing operations before income tax expense | (203,986 | ) | 24,362 | (193,083 | ) | 35,238 | |||||||||
Income tax expense (benefit) | (53,504 | ) | 8,223 | (47,756 | ) | 12,233 | |||||||||
Net income (loss) from continuing operations | (150,482 | ) | 16,139 | (145,327 | ) | 23,005 | |||||||||
Income (loss) from discontinued operations, net of tax | 309 | (970 | ) | 452 | (1,834 | ) | |||||||||
Net income (loss) | $ | (150,173 | ) | $ | 15,169 | $ | (144,875 | ) | $ | 21,171 | |||||
Net earnings (loss) per basic share: | |||||||||||||||
Net income (loss) from continuing operations | $ | (7.00 | ) | $ | 0.77 | $ | (6.80 | ) | $ | 1.09 | |||||
Income (loss) from discontinued operations, net of tax | 0.01 | (0.05 | ) | 0.02 | (0.09 | ) | |||||||||
Net income (loss) | $ | (6.99 | ) | $ | 0.72 | $ | (6.78 | ) | $ | 1.00 | |||||
Net earnings (loss) per diluted share: | |||||||||||||||
Net income (loss) from continuing operations | $ | (7.00 | ) | $ | 0.76 | $ | (6.80 | ) | $ | 1.07 | |||||
Income (loss) from discontinued operations, net of tax | 0.01 | (0.05 | ) | 0.02 | (0.08 | ) | |||||||||
Net income (loss) | $ | (6.99 | ) | $ | 0.71 | $ | (6.78 | ) | $ | 0.99 | |||||
Weighted average shares used in calculating earnings per share: | |||||||||||||||
Basic | 21,492 | 21,061 | 21,366 | 21,088 | |||||||||||
Diluted | 21,492 | 21,376 | 21,366 | 21,418 | |||||||||||
Comprehensive income (loss): | |||||||||||||||
Net income (loss) | $ | (150,173 | ) | $ | 15,169 | $ | (144,875 | ) | $ | 21,171 | |||||
Foreign currency translation adjustments, net of tax | 802 | (19 | ) | 1,226 | 2 | ||||||||||
Unrealized gain (loss) on investment, net of tax | (1,246 | ) | (597 | ) | 531 | 875 | |||||||||
Unrealized loss on cash flow hedging instruments, net of tax | (72 | ) | (34 | ) | (27 | ) | (148 | ) | |||||||
Other comprehensive income (loss) | (516 | ) | (650 | ) | 1,730 | 729 | |||||||||
Comprehensive income (loss) | $ | (150,689 | ) | $ | 14,519 | $ | (143,145 | ) | $ | 21,900 |
June 30, 2017 | December 31, 2016 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 13,592 | $ | 17,027 | |||
Receivables from clients, net | 93,083 | 94,246 | |||||
Unbilled services, net | 62,117 | 51,290 | |||||
Income tax receivable | 2,988 | 4,211 | |||||
Prepaid expenses and other current assets | 16,871 | 13,308 | |||||
Total current assets | 188,651 | 180,082 | |||||
Property and equipment, net | 46,977 | 32,434 | |||||
Deferred income taxes, net | 15,421 | — | |||||
Long-term investment | 35,546 | 34,675 | |||||
Other non-current assets | 28,565 | 24,814 | |||||
Intangible assets, net | 89,489 | 81,348 | |||||
Goodwill | 688,836 | 799,862 | |||||
Total assets | $ | 1,093,485 | $ | 1,153,215 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 8,107 | $ | 7,273 | |||
Accrued expenses and other current liabilities | 28,268 | 19,788 | |||||
Accrued payroll and related benefits | 51,549 | 82,669 | |||||
Accrued contingent consideration for business acquisitions | 6,107 | 1,985 | |||||
Deferred revenues | 24,689 | 24,053 | |||||
Total current liabilities | 118,720 | 135,768 | |||||
Non-current liabilities: | |||||||
Deferred compensation and other liabilities | 25,939 | 24,171 | |||||
Accrued contingent consideration for business acquisitions, net of current portion | 15,362 | 6,842 | |||||
Long-term debt, net of current portion | 400,173 | 292,065 | |||||
Deferred lease incentives | 15,284 | 10,703 | |||||
Deferred income taxes, net | — | 35,633 | |||||
Total non-current liabilities | 456,758 | 369,414 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity | |||||||
Common stock; $0.01 par value; 500,000,000 shares authorized; 24,512,482 and 24,126,118 shares issued at June 30, 2017 and December 31, 2016, respectively | 241 | 235 | |||||
Treasury stock, at cost, 2,417,257 and 2,408,343 shares at June 30, 2017 and December 31, 2016, respectively | (120,735 | ) | (113,195 | ) | |||
Additional paid-in capital | 426,983 | 405,895 | |||||
Retained earnings | 206,173 | 351,483 | |||||
Accumulated other comprehensive income | 5,345 | 3,615 | |||||
Total stockholders’ equity | 518,007 | 648,033 | |||||
Total liabilities and stockholders’ equity | $ | 1,093,485 | $ | 1,153,215 |
Six Months Ended June 30, | |||||||
2017 | 2016 | ||||||
Cash flows from operating activities: | |||||||
Net income (loss) | $ | (144,875 | ) | $ | 21,171 | ||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||
Depreciation and amortization | 24,705 | 22,201 | |||||
Share-based compensation | 7,601 | 9,787 | |||||
Amortization of debt discount and issuance costs | 5,031 | 4,757 | |||||
Goodwill impairment charge | 209,600 | — | |||||
Allowances for doubtful accounts and unbilled services | 1,292 | 5,877 | |||||
Deferred income taxes | (52,685 | ) | 4,879 | ||||
Gain on sale of business | (931 | ) | — | ||||
Change in fair value of contingent consideration liabilities | (1,102 | ) | — | ||||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
(Increase) decrease in receivables from clients | 10,948 | 19,818 | |||||
(Increase) decrease in unbilled services | (7,751 | ) | (26,552 | ) | |||
(Increase) decrease in current income tax receivable / payable, net | 959 | (570 | ) | ||||
(Increase) decrease in other assets | (2,951 | ) | 10,424 | ||||
Increase (decrease) in accounts payable and accrued liabilities | 6,976 | (4,594 | ) | ||||
Increase (decrease) in accrued payroll and related benefits | (32,426 | ) | (26,978 | ) | |||
Increase (decrease) in deferred revenues | (1,105 | ) | 1,187 | ||||
Net cash provided by operating activities | 23,286 | 41,407 | |||||
Cash flows from investing activities: | |||||||
Purchases of property and equipment, net | (15,287 | ) | (5,376 | ) | |||
Investment in life insurance policies | (1,826 | ) | (1,699 | ) | |||
Purchases of businesses, net of cash acquired | (103,456 | ) | (49,071 | ) | |||
Capitalization of internally developed software costs | (528 | ) | (536 | ) | |||
Proceeds from note receivable | 177 | — | |||||
Proceeds from sale of business | 1,499 | — | |||||
Net cash used in investing activities | (119,421 | ) | (56,682 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from exercise of stock options | — | 123 | |||||
Shares redeemed for employee tax withholdings | (4,259 | ) | (4,445 | ) | |||
Share repurchases | — | (55,265 | ) | ||||
Proceeds from borrowings under credit facility | 205,500 | 116,000 | |||||
Repayments on credit facility | (106,500 | ) | (93,000 | ) | |||
Payments for debt issuance costs | (395 | ) | — | ||||
Payment of contingent consideration liabilities | (1,811 | ) | — | ||||
Net cash provided by (used in) financing activities | 92,535 | (36,587 | ) | ||||
Effect of exchange rate changes on cash | 165 | 125 | |||||
Net decrease in cash and cash equivalents | (3,435 | ) | (51,737 | ) | |||
Cash and cash equivalents at beginning of the period | 17,027 | 58,437 | |||||
Cash and cash equivalents at end of the period | $ | 13,592 | $ | 6,700 |
Three Months Ended June 30, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2017 | 2016 | |||||||||
Healthcare: | |||||||||||
Revenues | $ | 83,227 | $ | 106,088 | (21.5 | )% | |||||
Operating income | $ | 23,652 | $ | 41,399 | (42.9 | )% | |||||
Segment operating income as a percentage of segment revenues | 28.4 | % | 39.0 | % | |||||||
Education: | |||||||||||
Revenues | $ | 43,926 | $ | 37,322 | 17.7 | % | |||||
Operating income | $ | 12,495 | $ | 11,482 | 8.8 | % | |||||
Segment operating income as a percentage of segment revenues | 28.4 | % | 30.8 | % | |||||||
Business Advisory: | |||||||||||
Revenues | $ | 54,265 | $ | 40,849 | 32.8 | % | |||||
Operating income | $ | 12,192 | $ | 10,856 | 12.3 | % | |||||
Segment operating income as a percentage of segment revenues | 22.5 | % | 26.6 | % | |||||||
Total Company: | |||||||||||
Revenues | $ | 181,418 | $ | 184,259 | (1.5 | )% | |||||
Reimbursable expenses | 20,930 | 18,982 | 10.3 | % | |||||||
Total revenues and reimbursable expenses | $ | 202,348 | $ | 203,241 | (0.4 | )% | |||||
Statements of Operations reconciliation: | |||||||||||
Segment operating income | $ | 48,339 | $ | 63,737 | (24.2 | )% | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses | 30,732 | 27,970 | 9.9 | % | |||||||
Other gains, net | (1,102 | ) | — | N/M | |||||||
Depreciation and amortization | 9,684 | 7,558 | 28.1 | % | |||||||
Goodwill impairment charge (1) | 209,600 | — | N/M | ||||||||
Total operating income (loss) | (200,575 | ) | 28,209 | N/M | |||||||
Other expense, net | 3,411 | 3,847 | (11.3 | )% | |||||||
Income (loss) from continuing operations before income tax expense | $ | (203,986 | ) | $ | 24,362 | N/M | |||||
Other Operating Data: | |||||||||||
Number of full-time billable consultants (at period end) (2): | |||||||||||
Healthcare | 750 | 952 | (21.2 | )% | |||||||
Education | 519 | 428 | 21.3 | % | |||||||
Business Advisory | 737 | 516 | 42.8 | % | |||||||
Total | 2,006 | 1,896 | 5.8 | % | |||||||
Average number of full-time billable consultants (for the period) (2): | |||||||||||
Healthcare | 807 | 1,005 | |||||||||
Education | 494 | 421 | |||||||||
Business Advisory | 725 | 472 | |||||||||
Total | 2,026 | 1,898 |
Three Months Ended June 30, | ||||||||
Other Operating Data (continued): | 2017 | 2016 | ||||||
Full-time billable consultant utilization rate (3): | ||||||||
Healthcare | 77.7 | % | 78.1 | % | ||||
Education | 75.1 | % | 72.4 | % | ||||
Business Advisory | 72.4 | % | 73.3 | % | ||||
Total | 75.1 | % | 75.6 | % | ||||
Full-time billable consultant average billing rate per hour (4): | ||||||||
Healthcare | $ | 182 | $ | 211 | ||||
Education | $ | 219 | $ | 217 | ||||
Business Advisory | $ | 190 | $ | 228 | ||||
Total | $ | 194 | $ | 216 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Healthcare | $ | 65 | $ | 76 | ||||
Education | $ | 80 | $ | 76 | ||||
Business Advisory | $ | 72 | $ | 82 | ||||
Total | $ | 71 | $ | 78 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Healthcare | 215 | 198 | ||||||
Education | 34 | 36 | ||||||
Business Advisory | 17 | 21 | ||||||
Total | 266 | 255 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Healthcare | $ | 143 | $ | 148 | ||||
Education | $ | 134 | $ | 149 | ||||
Business Advisory | $ | 133 | $ | 98 | ||||
Total | $ | 141 | $ | 144 |
Six Months Ended June 30, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2017 | 2016 | |||||||||
Healthcare: | |||||||||||
Revenues | $ | 181,679 | $ | 220,106 | (17.5 | )% | |||||
Operating income | $ | 57,802 | $ | 80,405 | (28.1 | )% | |||||
Segment operating income as a percentage of segment revenues | 31.8 | % | 36.5 | % | |||||||
Education: | |||||||||||
Revenues | $ | 86,207 | $ | 73,195 | 17.8 | % | |||||
Operating income | $ | 24,010 | $ | 20,577 | 16.7 | % | |||||
Segment operating income as a percentage of segment revenues | 27.9 | % | 28.1 | % | |||||||
Business Advisory: | |||||||||||
Revenues | $ | 102,381 | $ | 71,447 | 43.3 | % | |||||
Operating income | $ | 22,058 | $ | 14,668 | 50.4 | % | |||||
Segment operating income as a percentage of segment revenues | 21.5 | % | 20.5 | % | |||||||
Total Company: | |||||||||||
Revenues | $ | 370,267 | $ | 364,748 | 1.5 | % | |||||
Reimbursable expenses | 37,880 | 35,543 | 6.6 | % | |||||||
Total revenues and reimbursable expenses | $ | 408,147 | $ | 400,291 | 2.0 | % | |||||
Statements of Operations reconciliation: | |||||||||||
Segment operating income | $ | 103,870 | $ | 115,650 | (10.2 | )% | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses | 63,195 | 58,093 | 8.8 | % | |||||||
Other gains, net | (1,102 | ) | — | N/M | |||||||
Depreciation and amortization expense | 18,603 | 14,972 | 24.3 | % | |||||||
Goodwill impairment charge (1) | 209,600 | — | N/M | ||||||||
Total operating income (loss) | (186,426 | ) | 42,585 | N/M | |||||||
Other expense, net | 6,657 | 7,347 | (9.4 | )% | |||||||
Income (loss) from continuing operations before income tax expense | $ | (193,083 | ) | $ | 35,238 | N/M | |||||
Other Operating Data: | |||||||||||
Number of full-time billable consultants (at period end) (2): | |||||||||||
Healthcare | 750 | 952 | (21.2 | )% | |||||||
Education | 519 | 428 | 21.3 | % | |||||||
Business Advisory | 737 | 516 | 42.8 | % | |||||||
Total | 2,006 | 1,896 | 5.8 | % | |||||||
Average number of full-time billable consultants (for the period) (2): | |||||||||||
Healthcare | 837 | 1,015 | |||||||||
Education | 483 | 415 | |||||||||
Business Advisory | 675 | 433 | |||||||||
Total | 1,995 | 1,863 |
Six Months Ended June 30, | ||||||||
Other Operating Data (continued): | 2017 | 2016 | ||||||
Full-time billable consultant utilization rate (3): | ||||||||
Healthcare | 74.9 | % | 79.3 | % | ||||
Education | 75.0 | % | 72.9 | % | ||||
Business Advisory | 78.2 | % | 71.7 | % | ||||
Total | 76.1 | % | 76.1 | % | ||||
Full-time billable consultant average billing rate per hour (4): | ||||||||
Healthcare | $ | 205 | $ | 212 | ||||
Education | $ | 218 | $ | 216 | ||||
Business Advisory | $ | 194 | $ | 224 | ||||
Total | $ | 204 | $ | 215 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Healthcare | $ | 142 | $ | 158 | ||||
Education | $ | 157 | $ | 152 | ||||
Business Advisory | $ | 145 | $ | 158 | ||||
Total | $ | 147 | $ | 157 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Healthcare | 215 | 199 | ||||||
Education | 37 | 36 | ||||||
Business Advisory | 18 | 15 | ||||||
Total | 270 | 250 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Healthcare | $ | 293 | $ | 299 | ||||
Education | $ | 281 | $ | 277 | ||||
Business Advisory | $ | 236 | $ | 200 | ||||
Total | $ | 288 | $ | 290 |
(1) | The non-cash goodwill impairment charge is not allocated at the segment level because the underlying goodwill asset is reflective of Huron's corporate investment in the segments. Huron does not include the impact of goodwill impairment charges in its evaluation of segment performance. |
(2) | Consists of full-time professionals who provide consulting services and generate revenues based on the number of hours worked. |
(3) | Utilization rate for full-time billable consultants is calculated by dividing the number of hours all full-time billable consultants worked on client assignments during a period by the total available working hours for all of these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days. |
(4) | Average billing rate per hour for full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period. |
(5) | Consists of cultural transformation consultants within the Studer Group solution, which include coaches and their support staff, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients. |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Revenues | $ | 181,418 | $ | 184,259 | $ | 370,267 | $ | 364,748 | |||||||
Net income (loss) from continuing operations | $ | (150,482 | ) | $ | 16,139 | $ | (145,327 | ) | $ | 23,005 | |||||
Add back: | |||||||||||||||
Income tax expense (benefit) | (53,504 | ) | 8,223 | (47,756 | ) | 12,233 | |||||||||
Interest expense, net of interest income | 4,927 | 4,123 | 8,931 | 8,094 | |||||||||||
Depreciation and amortization | 12,429 | 11,398 | 24,334 | 22,198 | |||||||||||
Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA) (6) | (186,630 | ) | 39,883 | (159,818 | ) | 65,530 | |||||||||
Add back: | |||||||||||||||
Restructuring charges | 3,669 | 1,747 | 3,948 | 3,080 | |||||||||||
Other gains, net | (1,102 | ) | — | (1,102 | ) | — | |||||||||
Goodwill impairment charge | 209,600 | — | 209,600 | — | |||||||||||
Gain on sale of business | (931 | ) | — | (931 | ) | — | |||||||||
Foreign currency transaction gains | (81 | ) | (7 | ) | (64 | ) | (354 | ) | |||||||
Adjusted EBITDA (6) | $ | 24,525 | $ | 41,623 | $ | 51,633 | $ | 68,256 | |||||||
Adjusted EBITDA as a percentage of revenues (6) | 13.5 | % | 22.6 | % | 13.9 | % | 18.7 | % |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net income (loss) from continuing operations | $ | (150,482 | ) | $ | 16,139 | $ | (145,327 | ) | $ | 23,005 | |||||
Weighted average shares – diluted | 21,492 | 21,376 | 21,366 | 21,418 | |||||||||||
Diluted earnings (loss) per share from continuing operations | $ | (7.00 | ) | $ | 0.76 | $ | (6.80 | ) | $ | 1.07 | |||||
Add back: | |||||||||||||||
Amortization of intangible assets | 8,945 | 8,153 | 17,597 | 15,598 | |||||||||||
Restructuring charges | 3,669 | 1,747 | 3,948 | 3,080 | |||||||||||
Other gains, net | (1,102 | ) | — | (1,102 | ) | — | |||||||||
Goodwill impairment charge | 209,600 | — | 209,600 | — | |||||||||||
Non-cash interest on convertible notes | 1,951 | 1,861 | 3,879 | 3,699 | |||||||||||
Gain on sale of business | (931 | ) | — | (931 | ) | — | |||||||||
Tax effect | (61,070 | ) | (4,622 | ) | (65,262 | ) | (8,794 | ) | |||||||
Total adjustments, net of tax | 161,062 | 7,139 | 167,729 | 13,583 | |||||||||||
Adjusted net income from continuing operations (6) | $ | 10,580 | $ | 23,278 | $ | 22,402 | $ | 36,588 | |||||||
Adjusted weighted average shares - diluted (7) | 21,657 | 21,376 | 21,566 | 21,418 | |||||||||||
Adjusted diluted earnings per share from continuing operations (6) | $ | 0.49 | $ | 1.09 | $ | 1.04 | $ | 1.71 |
(6) | In evaluating the company’s financial performance and outlook, management uses earnings (loss) before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income (loss) from continuing operations, and adjusted diluted earnings (loss) per share from continuing operations, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing the company's business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States. |
(7) | As the company reported a net loss for the three and six months ended June 30, 2017, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for those periods. The non-GAAP adjustments described above resulted in adjusted net income from continuing operations for those periods. Therefore, dilutive common stock equivalents have been included in the calculation of adjusted diluted weighted average shares outstanding. |
Year Ending | |||||||
December 31, 2017 | |||||||
Guidance Range | |||||||
Low | High | ||||||
Projected revenues - GAAP | $ | 730.0 | $ | 750.0 | |||
Projected net loss - GAAP | $ | (134.0 | ) | $ | (131.0 | ) | |
Add back: | |||||||
Income tax benefit | (44.0 | ) | (41.0 | ) | |||
Interest expense, net of interest income | 18.0 | 18.0 | |||||
Depreciation and amortization | 49.0 | 49.0 | |||||
Projected loss before interest, taxes, depreciation and amortization (EBITDA) (8) | (111.0 | ) | (105.0 | ) | |||
Add back: | |||||||
Restructuring charges | 5.0 | 5.0 | |||||
Other gains, net | (1.0 | ) | (1.0 | ) | |||
Goodwill impairment charge | 210.0 | 210.0 | |||||
Other non-operating income, net | (1.0 | ) | (1.0 | ) | |||
Projected adjusted EBITDA (8) | $ | 102.0 | $ | 108.0 | |||
Projected adjusted EBITDA as a percentage of projected revenues (8) | 14.0 | % | 14.4 | % |
Year Ending | |||||||
December 31, 2017 | |||||||
Guidance Range | |||||||
Low | High | ||||||
Projected net loss - GAAP | $ | (134.0 | ) | $ | (131.0 | ) | |
Projected diluted loss per share - GAAP | $ | (6.25 | ) | $ | (6.15 | ) | |
Add back: | |||||||
Amortization of intangible assets | 35.0 | 35.0 | |||||
Restructuring charges | 5.0 | 5.0 | |||||
Other gains, net | (1.0 | ) | (1.0 | ) | |||
Goodwill impairment charge | 210.0 | 210.0 | |||||
Non-cash interest on convertible notes | 8.0 | 8.0 | |||||
Gain on sale of business | (1.0 | ) | (1.0 | ) | |||
Tax effect | (75.0 | ) | (75.0 | ) | |||
Total adjustments, net of tax | 181.0 | 181.0 | |||||
Projected adjusted net income (8) | $ | 47.0 | $ | 50.0 | |||
Projected adjusted diluted earnings per share (8) | $ | 2.20 | $ | 2.30 |
(8) | In evaluating the company’s outlook, management uses projected EBITDA, projected adjusted EBITDA, projected adjusted EBITDA as a percentage of revenues, projected adjusted net income, and projected adjusted diluted earnings per share, which are non-GAAP measures. Management believes that the use of such measures, as supplements to projected net loss and projected diluted loss per share, and other GAAP measures, are useful indicators for investors. These useful indicators can help readers gain a meaningful understanding of the company’s core operating results and future prospects without the effect of non-cash or other one-time items. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States. |